Dabin Lin News Today

The wearable device, designed to monitor bladder and kidney health, could be adapted for earlier diagnosis of cancers deep within the body. MIT researchers have designed a wearable ultrasound monitor, in the form of a patch, that can image organs within the body without the need for an ultrasound

Get latest articles and stories on Science at LatestLY. MIT researchers have created a patch-like wearable ultrasound monitor that can inspect organs within the body without the need for an ultrasound operator or the use of gel. Science News | Researchers Create New Ultrasound Patch That Can Determine How Full Bladder is.

The researchers have developed a patch-like wearable ultrasound monitor that can inspect the internal organs of the body. | Health

A wearable ultrasound monitor can image the bladder and determine how full it is. The MIT-developed device could help patients with bladder or kidney disorders more easily track whether these organs are functioning properly.

Get latest articles and stories on Science at LatestLY. MIT researchers have created a patch-like wearable ultrasound monitor that can examine organs within the body without the use of an ultrasound operator or the application of the gel. Science News | Researchers Develop Ultrasound Patch to Measure How Full Bladder is.

Using an attachable patch to the bra, the wearable ultrasound cancer scanner developed by MIT researchers takes images of the breast tissue.

USA: Researchers from the Massachusetts Institute of Technology (MIT) have designed an ultrasound device that could allow people to detect tumours when they are still in their early stages. It could...

When breast cancer is diagnosed in the earliest stages, the survival rate is nearly 100 percent. However, for tumors detected in later stages, that rate drops to around 25 percent.

The new device could allow more frequent monitoring of patients at high risk for breast cancer.

Senior author and MIT professor Canan Dagdeviren said the device will aim to increase the survival rate of interval breast cancer to 98pc.